JPS59184106A - 抗糸状菌剤 - Google Patents

抗糸状菌剤

Info

Publication number
JPS59184106A
JPS59184106A JP59056374A JP5637484A JPS59184106A JP S59184106 A JPS59184106 A JP S59184106A JP 59056374 A JP59056374 A JP 59056374A JP 5637484 A JP5637484 A JP 5637484A JP S59184106 A JPS59184106 A JP S59184106A
Authority
JP
Japan
Prior art keywords
imidazole
following formula
solvents
methane
extender
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59056374A
Other languages
English (en)
Japanese (ja)
Inventor
カルルハインツ・アダムス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS59184106A publication Critical patent/JPS59184106A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP59056374A 1983-03-30 1984-03-26 抗糸状菌剤 Pending JPS59184106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE33117012 1983-03-30
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (1)

Publication Number Publication Date
JPS59184106A true JPS59184106A (ja) 1984-10-19

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59056374A Pending JPS59184106A (ja) 1983-03-30 1984-03-26 抗糸状菌剤

Country Status (19)

Country Link
JP (1) JPS59184106A (it)
KR (1) KR840008284A (it)
AU (1) AU564956B2 (it)
BE (1) BE899278A (it)
CA (1) CA1212327A (it)
CH (1) CH660126A5 (it)
CY (1) CY1358A (it)
DE (1) DE3311701A1 (it)
ES (3) ES8503947A1 (it)
FR (1) FR2543435B1 (it)
GB (1) GB2137091B (it)
GR (1) GR81485B (it)
IT (1) IT1173761B (it)
KE (1) KE3704A (it)
LU (1) LU85271A1 (it)
PH (1) PH20420A (it)
PT (1) PT78313B (it)
SE (1) SE8401748L (it)
ZA (1) ZA842337B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5191260A (en) * 1974-12-24 1976-08-10 Azoriruu*1* metanruioyobi soreranoennoseizohoho
JPS57122016A (en) * 1980-12-05 1982-07-29 Bayer Ag Antimycotic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5191260A (en) * 1974-12-24 1976-08-10 Azoriruu*1* metanruioyobi soreranoennoseizohoho
JPS57122016A (en) * 1980-12-05 1982-07-29 Bayer Ag Antimycotic

Also Published As

Publication number Publication date
ES539290A0 (es) 1985-11-16
GB2137091A (en) 1984-10-03
ES8601693A1 (es) 1985-11-16
CH660126A5 (de) 1987-03-31
DE3311701A1 (de) 1984-10-04
AU2623684A (en) 1984-10-04
IT8420303A0 (it) 1984-03-29
SE8401748D0 (sv) 1984-03-29
FR2543435A1 (fr) 1984-10-05
ES8601692A1 (es) 1985-11-16
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
FR2543435B1 (fr) 1988-06-17
SE8401748L (sv) 1984-10-01
CA1212327A (en) 1986-10-07
ES539289A0 (es) 1985-11-16
PH20420A (en) 1987-01-05
KE3704A (en) 1987-03-27
GB2137091B (en) 1986-10-01
CY1358A (en) 1987-08-07
ES530846A0 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
AU564956B2 (en) 1987-09-03
BE899278A (fr) 1984-10-01
PT78313A (en) 1984-04-01
GB8408067D0 (en) 1984-05-10
GR81485B (it) 1984-12-11
IT1173761B (it) 1987-06-24
ES8503947A1 (es) 1985-04-16
KR840008284A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
DE68912459T2 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
KR930019638A (ko) 이미다졸 화합물, 이의 제조방법 및 용도
EP0396069B1 (de) Salze des Azelastins mit verbesserter Löslichkeit
PL185294B1 (pl) Przeciwświądowe kompozycje kosmetyczne i/lub farmaceutyczne, ich zastosowanie do wytwarzania leków i sposób ich wytwarzania
JPH0380775B2 (it)
JPH0645542B2 (ja) イミダゾ−ル−エタノ−ルエステル
CH656800A5 (de) Immunomodulierendes mittel.
EP0058887A1 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Stiften
EP0708100B1 (fr) Nouveaux composés dérivés du dibenzofuranne, compositions pharmaceutiques et cosmétiques les contenant
JP2594376B2 (ja) 新規ウレタン誘導体、その製造法及びこれを含有する化粧料又は医薬組成物
JP5048500B2 (ja) 鏡像異性イミダゾール化合物の製造方法
EP0443956B1 (fr) Acylats d'acide lactique, leurs sels, leur procédé de préparation et les compositions les renfermant
JPS59184106A (ja) 抗糸状菌剤
CA1142854A (en) Method and compositions for the treatment of seborrhea
JP2991680B2 (ja) 新規な抗フリーラジカルメラトニン誘導体、及びこれを含有する組成物
JPH08208460A (ja) 抗炎症剤
DE60103284T2 (de) Antifungizide zusammensetzung von ketoconazole zum auftragen
KR100234627B1 (ko) 항 자극제로서 사용하기 위한 제제
JPS59184125A (ja) 抗糸状菌剤
JPS6338969B2 (it)
JPH07173053A (ja) 抗微生物剤
DE1926359A1 (de) oxylkansaeuren
JP3453462B2 (ja) 化粧料
JPS59108713A (ja) 抗糸状菌性ゲル及びその製造方法
JPH05271226A (ja) 創傷治癒促進剤